Onconetix (ONCO) Other Accumulated Expenses (2022 - 2026)
Onconetix (ONCO) posted quarterly Other Accumulated Expenses of $16750.0 for Q1 2026, down 87.96% year-over-year from $139082.0 in Q1 2025, and down 9.19% quarter-over-quarter from $18445.0 in Q4 2025.
Onconetix (ONCO) Other Accumulated Expenses (2022 - 2026) Analysis & Trends
Onconetix (ONCO) has reported Other Accumulated Expenses for 5 consecutive years, with $16750.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Accumulated Expenses fell 87.96% year-over-year to $16750.0; the TTM figure through Mar 2026 stood at $16750.0 (down 87.96% YoY), while the FY2025 annual figure was $18445.0, down 28.62% from the prior year.
- Other Accumulated Expenses eased to $16750.0 in Q1 2026 per ONCO's latest filing, from $18445.0 in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $177600.0 in Q4 2022 and bottomed at $11171.0 in Q2 2025.
- Historically, Other Accumulated Expenses has averaged $66083.7 across 5 years, with a median of $45000.0 in 2024.
- On a YoY basis, Other Accumulated Expenses climbed as much as 178.16% in 2025 and fell as far as 88.83% in 2025.
- Onconetix's Other Accumulated Expenses stood at $177600.0 in 2022, then slumped by 65.92% to $60530.0 in 2023, then slumped by 57.31% to $25841.0 in 2024, then fell by 28.62% to $18445.0 in 2025, then fell by 9.19% to $16750.0 in 2026.
- Business Quant data shows ONCO's Other Accumulated Expenses at $16750.0 in Q1 2026, $18445.0 in Q4 2025, and $19324.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Onconetix | 1.44 Mn | -4.50 Mn | 4,303.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 80,000.00 |
| Mar 31, 2026 | 16,750.00 |
| Dec 31, 2025 | 18,445.00 |
| Sep 30, 2025 | 19,324.00 |
| Jun 30, 2025 | 11,171.00 |
| Mar 31, 2025 | 139,082.00 |
| Dec 31, 2024 | 25,841.00 |
| Sep 30, 2024 | 40,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 50,000.00 |
| Dec 31, 2023 | 60,530.00 |
| Jun 30, 2023 | 134,261.00 |
| Dec 31, 2022 | 177,600.00 |